Table 3.

Sequential Analysis of p15INK4b Methylation in 10 MDS Cases

Patient No.
1 2 34 5 6 7 8 9 10
First analysis 
 FAB type  RAEB  RAEB  RAEB  RAEB-t  RAEB  CMML RAEB  RAEB  RAEB-t  RAEB  
 % bone marrow blasts  11  8  26  9  4  12  12  23  15 
 Methylation status  U  U  U  U  U  U  M  M  M  
Second analysis 
 Interval between first and second analysis (mo)  17  18 4  4  11  7  11  3  8  14  
 % Bone marrow blasts  66  35  74  69  67  65  80  35  28 40  
 Methylation status  M  M  M  U  M  M  M  M  M  
Third analysis 
 Interval between second and third analysis (mo)       12  2  
 % bone marrow blasts    41*   27* 23* 
 Methylation status       M  M    
Patient No.
1 2 34 5 6 7 8 9 10
First analysis 
 FAB type  RAEB  RAEB  RAEB  RAEB-t  RAEB  CMML RAEB  RAEB  RAEB-t  RAEB  
 % bone marrow blasts  11  8  26  9  4  12  12  23  15 
 Methylation status  U  U  U  U  U  U  M  M  M  
Second analysis 
 Interval between first and second analysis (mo)  17  18 4  4  11  7  11  3  8  14  
 % Bone marrow blasts  66  35  74  69  67  65  80  35  28 40  
 Methylation status  M  M  M  U  M  M  M  M  M  
Third analysis 
 Interval between second and third analysis (mo)       12  2  
 % bone marrow blasts    41*   27* 23* 
 Methylation status       M  M    

Abbreviations: U, unmethylated; M, methylated.

*

Third analysis performed after intensive chemotherapy, which yielded only transient reduction in the bone marrow blast count.

or Create an Account

Close Modal
Close Modal